For example, METTL3, the catalytic core component of the m6A methyltransferase complex, is frequently upregulated in advanced cancers such as lung adenocarcinoma, hepatocellular carcinoma, pancreatic cancer, and colorectal carcinoma [60,61,62,63]. Here, METTL3 is linked to hepatocellular carcinoma.